Leadership & Pay ·
ARS Pharmaceuticals, Inc. announced that its Board of Directors appointed current President Donn Casale as Chief…
SPRYARS Pharmaceuticals, Inc.
ARS Pharmaceuticals, Inc. announced that its Board of Directors appointed current President Donn Casale as Chief Executive Officer, effective July 7, 2026. Casale also joined the Board as a Class III director with a term ending at the 2029 annual meeting. This appointment replaces Richard Lowenthal, who was terminated without cause effective immediately on July 6, 2026. ARS Pharmaceuticals, Inc. is a biopharmaceutical company.